EcoDrugPlus

Adrenoceptor Alpha 2b

Ensembl ID : ENSMMMG00000001017
Gene Symbol: ADRA2B
3 Cross references
219 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSMMMG00000014251
Gene Symbol: ADRA2C
1 Cross references
227 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSMMMG00000003558
Gene Symbol: ADRB1
3 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSMMMG00000019082
Gene Symbol: ADRB2
3 Cross references
263 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSMMMG00000015315
Gene Symbol: ADRB3
1 Cross references
215 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSMMMG00000018005
Gene Symbol: AGER
3 Cross references
169 Possible Orthologues:

Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide

Ensembl ID : ENSMMMG00000007886
Gene Symbol: ADH5
3 Cross references
400 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSMMMG00000012887
Gene Symbol: AKR1B1
3 Cross references
428 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSMMMG00000007321
Gene Symbol: GAA
3 Cross references
234 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSMMMG00000006352
Gene Symbol: AOC1
3 Cross references
230 Possible Orthologues:

Amyloid P Component, Serum

Ensembl ID : ENSMMMG00000022435
Gene Symbol: APCS
3 Cross references
440 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSMMMG00000017280
Gene Symbol: APP
3 Cross references
276 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).